Echocardiography in hypertrophic cardiomyopathy: the role of conventional and emerging technologies.
Hypertrophic cardiomyopathy is a relatively common inherited cardiomyopathy that is occasionally challenging to differentiate from hypertensive heart disease and athlete hearts on the basis of morphologic or functional abnormalities alone. Echocardiography has traditionally played a preeminent role in the diagnosis, formulation of management strategies, and the prognostication of this complex disease. In this review, we briefly profile the utility and pitfalls of established echocardiographic modalities and discuss the evolving role of novel echocardiographic imaging modalities such as tissue Doppler, Doppler-based strain, 2-dimensional strain (speckle tracking imaging), and 3-dimensional imaging in the assessment of hypertrophic cardiomyopathy.
Division of Cardiology, Wayne State University, Detroit, Michigan, USA.
Luis C
LC
Afonso
Juan
J
Bernal
Jeroen J
JJ
Bax
Theodore P
TP
Abraham
D002312:Cardiomyopathy, Hypertrophic / Q000000981:diagnostic imaging* / Q000503:physiopathology; D003287:Contrast Media; D003937:Diagnosis, Differential; D004452:Echocardiography / Q000379:methods / Q000639:trends; D015150:Echocardiography, Doppler; D018618:Echocardiography, Doppler, Color; D019560:Echocardiography, Three-Dimensional; D006801:Humans; D007090:Image Interpretation, Computer-Assisted; D011237:Predictive Value of Tests; D011379:Prognosis
D003287:Contrast Media